Ralexar Therapeutics, Inc., headquartered in Malvern, Pennsylvania, is a privately held specialty pharmaceutical company founded in January of 2014. The company is developing topical and systemic therapies based on Liver X Receptor (LXR) modulators. The initial focus for the company will be on developing ALX-101, a topical LXR-based therapy , for the treatment of various cutaneous inflammatory disorders.
View Top Employees from Ralexar Therapeutics Inc| Website | http://www.ralexar.com |
| Revenue | $10 million |
| Funding | $14.7 million |
| Employees | View employees |
| Founded | 2013 |
| Address | 640 Lee Rd, Ste 118, Wayne, Pennsylvania 19087, US |
| Phone | (484) 318-2988 |
| Fax | (484) 324-7949 |
| Technologies | |
| Industry | Biotechnology, Drug Manufacturing & Research, Pharmaceuticals, Science and Engineering, Drug Discovery, Healthcare, Clinical Trials, Health Care, Therapeutics |
| Competitors | Anthem Biosciences Private Limited, G V K Biosciences Private Limited, NeXeption, LLC, Onyx Scientific, Syngene -Clinical Development |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies |
Looking for a particular Ralexar Therapeutics Inc employee's phone or email?
Ralexar Therapeutics Inc Questions
The Ralexar Therapeutics Inc annual revenue was $10 million in 2024.
Ralexar Therapeutics Inc is based in Wayne, Pennsylvania.
The NAICS codes for Ralexar Therapeutics Inc are [32, 3254, 32541, 325].
The SIC codes for Ralexar Therapeutics Inc are [28, 283].
